VR Logo

Gufic Biosciences Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 986.11 Cr

Revenue (TTM): R 400.49 Cr

Earnings (TTM): R 30.48 Cr

Cash: R 10.82 Cr

Total Debt: R 110.73 Cr

Promoters' ownership: 65.75%

Liquidity: High

52 Week range: R 45.90 - 137.45

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

  • CFO: 71.12 Cr
  • EBITDA: 222.50 Cr
  • Net Profit: 92.36 Cr

Stock Performance

Time Period Gufic Biosciences S&P BSE Healthcare S&P BSE Small Cap
YTD8.347.8714.79
1 month19.3013.831.49
3 months3.986.8710.84
1 Year97.9756.9390.83
3 Years0.7519.144.55
5 Years25.218.4713.28
10 Years35.7214.268.87
As on 20-Apr-2021
Year Gufic Biosciences S&P BSE Small Cap S&P BSE Healthcare
202093.4732.1161.45
2019-35.40-6.85-3.55
2018-26.15-23.41-5.89
2017138.2559.640.49
2016-4.491.77-12.88
2015225.156.7615.06